• Mashup Score: 1
    What is TAKEheart? - 7 month(s) ago

    TAKEheart is an AHRQ initiative to help hospitals increase patient participation in cardiac rehabilitation (CR).

    Tweet Tweets with this article
    • Patients deserve the best in cardiac care. #AHRQ's TAKEHeart initiative underscores the effects of cardiac rehabilitation. This #CholesterolEducationMonth, we invite hospitals to use these resources, fostering a culture of comprehensive heart health. https://t.co/5AOc0qhxWX https://t.co/Qs199lpHey

  • Mashup Score: 11

    Abstract Background Preventive therapy among patients with established atherosclerotic cardiovascular disease (ASCVD) is generally underused. Whether new guideline recommendations and a focus on im…

    Tweet Tweets with this article
    • Studies highlight concerns over non-adherence to statin therapy. It's crucial for patients to understand the importance of consistent medication. Read more: https://t.co/8rd1CF2EfZ #HealthAwareness #StatinAdherence #CholesterolEducationMonth https://t.co/dF6BQiB36l

    • Studies highlight concerns over non-adherence to statin therapy. It's crucial for patients to understand the importance of consistent medication. Read more: https://t.co/8rd1CF2EfZ #HealthAwareness #StatinAdherence #CholesterolEducationMonth https://t.co/Rax6UQu7mT

  • Mashup Score: 9

    WHAT WE DO Awareness, Education, Advocacy + Equality The Foundation of the National Lipid Association is a 501(c)(3) organization  formed in 2008 to serve as a patient education organization in the field of clinical lipidology. We are focused on providing education, advocacy, and resources to help patients and their families manage and overcome lipid-related health […]

    Tweet Tweets with this article
    • The NLA encourages adults over the age of 20 to get their lipids measured at least once every 5 years. Encourage your patients to understand why they should get lipid testing. They can access resources at https://t.co/XWKXG40hsF @foundationofnla #CholesterolEducationMonth https://t.co/8hMXuIBf42